Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.

Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators.

Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308. [Epub ahead of print]

PMID:
31557056
2.

Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.

Vora AN, Alexander JH, Wojdyla D, Aronson R, Granger CB, Darius H, Windecker S, Mehran R, Averkov O, Budaj AJ, Kong DF, Kobalava Z, Mehta RH, Mirza Z, Guimaraes PO, Parkhomenko A, Quadros A, Thiele H, Goodman SG, Lopes RD.

Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754. [Epub ahead of print]

PMID:
31553201
3.

Procedural Success Rates and Mortality in Elderly Patients With Percutaneous Coronary Intervention for Cardiogenic Shock.

Zeymer U, Hochadel M, Karcher AK, Thiele H, Darius H, Behrens S, Schumacher B, Ince H, Hoffmeister HM, Werner N, Zahn R; ALKK Study Group.

JACC Cardiovasc Interv. 2019 Sep 23;12(18):1853-1859. doi: 10.1016/j.jcin.2019.04.027.

PMID:
31537286
4.

Ciguatera poisoning in French Polynesia: insights into the novel trends of an ancient disease.

Chinain M, Gatti CM, Roué M, Darius HT.

New Microbes New Infect. 2019 Jun 7;31:100565. doi: 10.1016/j.nmni.2019.100565. eCollection 2019 Sep. Review.

5.

Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial.

Montalescot G, Brotons C, Cosyns B, Crijns HJ, D'Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators.

Am J Cardiovasc Drugs. 2019 Jun 26. doi: 10.1007/s40256-019-00356-2. [Epub ahead of print]

PMID:
31243691
6.

Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry.

Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Farjat AE, Zaghdoun A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Darius H, Kakkar AK.

Thromb Haemost. 2019 Aug;119(8):1365-1372. doi: 10.1055/s-0039-1688828. Epub 2019 Jun 10.

PMID:
31183844
7.

Ostreopsis lenticularis Y. Fukuyo (Dinophyceae, Gonyaulacales) from French Polynesia (South Pacific Ocean): A revisit of its morphology, molecular phylogeny and toxicity.

Chomérat N, Bilien G, Derrien A, Henry K, Ung A, Viallon J, Darius HT, Mahana Iti Gatti C, Roué M, Hervé F, Réveillon D, Amzil Z, Chinain M.

Harmful Algae. 2019 Apr;84:95-111. doi: 10.1016/j.hal.2019.02.004. Epub 2019 Mar 22.

PMID:
31128817
8.

Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI Registry.

Liosis S, Hochadel M, Darius H, Behrens S, Mudra H, Lauer B, Elsässer A, Gitt AK, Zahn R, Zeymer U; ALKK study group.

Int J Cardiol. 2019 Oct 1;292:43-49. doi: 10.1016/j.ijcard.2019.04.071. Epub 2019 Apr 25.

PMID:
31088759
9.

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.

10.

[Antithrombotic treatment in acute coronary syndrome and atrial fibrillation].

Darius H, Görge G, Spiecker M, Schinzel H.

Herz. 2019 Feb;44(1):29-34. doi: 10.1007/s00059-019-4781-z. German.

PMID:
30689009
11.

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee.

Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26.

PMID:
30158069
12.

Detection of pacific ciguatoxins using liquid chromatography coupled to either low or high resolution mass spectrometry (LC-MS/MS).

Sibat M, Herrenknecht C, Darius HT, Roué M, Chinain M, Hess P.

J Chromatogr A. 2018 Oct 12;1571:16-28. doi: 10.1016/j.chroma.2018.08.008. Epub 2018 Aug 4. Review.

PMID:
30100527
13.

The German CPU registry: Comparison of smokers and nonsmokers.

Bock D, Senges J, Pohlmann C, Hochadel M, Münzel T, Giannitsis E, Schmitt C, Heusch G, Voigtländer T, Mudra H, Schumacher B, Darius H, Maier LS, Hailer B, Haude M, Gohlke H, Hink U.

Herz. 2018 Jul 27. doi: 10.1007/s00059-018-4733-z. [Epub ahead of print]

PMID:
30054712
14.

Investigation of ciguatoxins in invasive lionfish from the greater caribbean region: Implications for fishery development.

Hardison DR, Holland WC, Darius HT, Chinain M, Tester PA, Shea D, Bogdanoff AK, Morris JA Jr, Flores Quintana HA, Loeffler CR, Buddo D, Litaker RW.

PLoS One. 2018 Jun 20;13(6):e0198358. doi: 10.1371/journal.pone.0198358. eCollection 2018.

15.
16.

Experimental evidence of dietary ciguatoxin accumulation in an herbivorous coral reef fish.

Clausing RJ, Losen B, Oberhaensli FR, Darius HT, Sibat M, Hess P, Swarzenski PW, Chinain M, Dechraoui Bottein MY.

Aquat Toxicol. 2018 Jul;200:257-265. doi: 10.1016/j.aquatox.2018.05.007. Epub 2018 May 26.

PMID:
29803968
17.

Tissue Distribution and Elimination of Ciguatoxins in Tridacna maxima (Tridacnidae, Bivalvia) Fed Gambierdiscus polynesiensis.

Roué M, Darius HT, Ung A, Viallon J, Sibat M, Hess P, Amzil Z, Chinain M.

Toxins (Basel). 2018 May 10;10(5). pii: E189. doi: 10.3390/toxins10050189.

18.

[Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Hoffmeister HM, Darius H, Buerke M.

Med Klin Intensivmed Notfmed. 2018 May;113(4):284-292. doi: 10.1007/s00063-018-0436-8. Epub 2018 May 4. Review. German.

PMID:
29728712
19.

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?

Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schäfer A, Thiele H, Bode C, Zeymer U.

Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20. Review.

PMID:
29679144
20.

Solid Phase Adsorption Toxin Tracking (SPATT) Technology for the Monitoring of Aquatic Toxins: A Review.

Roué M, Darius HT, Chinain M.

Toxins (Basel). 2018 Apr 20;10(4). pii: E167. doi: 10.3390/toxins10040167. Review.

21.

Toxicological Investigations on the Sea Urchin Tripneustes gratilla (Toxopneustidae, Echinoid) from Anaho Bay (Nuku Hiva, French Polynesia): Evidence for the Presence of Pacific Ciguatoxins.

Darius HT, Roué M, Sibat M, Viallon J, Gatti CMII, Vandersea MW, Tester PA, Litaker RW, Amzil Z, Hess P, Chinain M.

Mar Drugs. 2018 Apr 6;16(4). pii: E122. doi: 10.3390/md16040122.

22.

Guideline-adherence regarding critical time intervals in the German Chest Pain Unit registry.

Vafaie M, Hochadel M, Münzel T, Hailer B, Schumacher B, Heusch G, Voigtländer T, Mudra H, Haude M, Barth S, Schmitt C, Darius H, Maier LS, Katus HA, Senges J, Giannitsis E.

Eur Heart J Acute Cardiovasc Care. 2018 Mar 1:2048872618762639. doi: 10.1177/2048872618762639. [Epub ahead of print]

PMID:
29543035
23.

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Clinical Characterization and Follow-Up of a Mass Poisoning Event in Nuku Hiva Island (French Polynesia).

Gatti CMI, Lonati D, Darius HT, Zancan A, Roué M, Schicchi A, Locatelli CA, Chinain M.

Toxins (Basel). 2018 Feb 28;10(3). pii: E102. doi: 10.3390/toxins10030102.

24.

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.

Sherwood MW, Lopes RD, Sun JL, Liaw D, Harrington RA, Wallentin L, Laskowitz DT, James SK, Goodman SG, Darius H, Lewis BS, Gibson CM, Pieper KS, Alexander JH.

Am Heart J. 2018 Mar;197:1-8. doi: 10.1016/j.ahj.2017.09.020. Epub 2017 Oct 24.

PMID:
29447769
25.

Invasive treatment of NSTEMI patients in German Chest Pain Units - Evidence for a treatment paradox.

Schmidt FP, Schmitt C, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T; German Chest Pain Unit Registry.

Int J Cardiol. 2018 Mar 15;255:15-19. doi: 10.1016/j.ijcard.2017.11.018.

26.

Ciguatoxins activate the Calcineurin signalling pathway in Yeasts: Potential for development of an alternative detection tool?

Martin-Yken H, Gironde C, Derick S, Darius HT, Furger C, Laurent D, Chinain M.

Environ Res. 2018 Apr;162:144-151. doi: 10.1016/j.envres.2017.12.022. Epub 2018 Jan 4.

PMID:
29306662
27.

Application of solid phase adsorption toxin tracking (SPATT) devices for the field detection of Gambierdiscus toxins.

Roué M, Darius HT, Viallon J, Ung A, Gatti C, Harwood DT, Chinain M.

Harmful Algae. 2018 Jan;71:40-49. doi: 10.1016/j.hal.2017.11.006. Epub 2017 Dec 8.

PMID:
29306395
28.

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Detection of Pacific Ciguatoxins in Toxic Samples from Nuku Hiva Island (French Polynesia).

Darius HT, Roué M, Sibat M, Viallon J, Gatti CMI, Vandersea MW, Tester PA, Litaker RW, Amzil Z, Hess P, Chinain M.

Toxins (Basel). 2017 Dec 21;10(1). pii: E2. doi: 10.3390/toxins10010002.

29.

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.

De Caterina R, Brüggenjürgen B, Darius H, Köhler S, Lucerna M, Pecen L, Renda G, Schilling RJ, Schliephacke T, Zamorano JL, Le Heuzey JY, Kirchhof P.

Arch Cardiovasc Dis. 2018 Feb;111(2):74-84. doi: 10.1016/j.acvd.2017.04.007. Epub 2017 Sep 21.

30.

Corrigendum to "Evidence of the bioaccumulation of ciguatoxins in giant clams (Tridacna maxima) exposed to Gambierdiscus spp. cells" [Harmful Algae 57 (2016) 78-87].

Roué M, Darius HT, Picot S, Ung A, Viallon J, Gaertner-Mazouni N, Sibat M, Amzil Z, Chinain M.

Harmful Algae. 2017 Mar;63:204. doi: 10.1016/j.hal.2017.01.005. Epub 2017 Jan 31. No abstract available.

PMID:
28366395
31.

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation.

Schnabel RB, Pecen L, Ojeda FM, Lucerna M, Rzayeva N, Blankenberg S, Darius H, Kotecha D, Caterina R, Kirchhof P.

Heart. 2017 Jul;103(13):1024-1030. doi: 10.1136/heartjnl-2016-310406. Epub 2017 Feb 22.

32.

Characterization and referral patterns of ST-elevation myocardial infarction patients admitted to chest pain units rather than directly to catherization laboratories. Data from the German Chest Pain Unit Registry.

Schmidt FP, Perne A, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T; German Chest Pain Unit Registry.

Int J Cardiol. 2017 Mar 15;231:31-35. doi: 10.1016/j.ijcard.2016.12.017.

PMID:
28189192
33.

[NOAC: Real-life data and the role of antidotes for the treatment of bleeding].

Darius H.

Med Klin Intensivmed Notfmed. 2017 Mar;112(2):99-104. doi: 10.1007/s00063-016-0258-5. Epub 2017 Jan 31. Review. German.

PMID:
28144725
34.

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK; GARFIELD-AF Investigators.

PLoS One. 2016 Oct 28;11(10):e0164076. doi: 10.1371/journal.pone.0164076. eCollection 2016.

35.

Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.

Bakhai A, Darius H, De Caterina R, Smart A, Le Heuzey JY, Schilling RJ, Zamorano JL, Shah M, Bramlage P, Kirchhof P.

Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):299-305. doi: 10.1093/ehjqcco/qcw031.

PMID:
29474715
36.

[Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].

Helms TM, Silber S, Schäfer A, Masuhr F, Palm F, Darius H, Schrör K, Bänsch D, Bramlage P, Hankowitz J, Karle CA, Stargardt T, Weil J, Geller JC.

Herzschrittmacherther Elektrophysiol. 2016 Sep;27(3):295-306. doi: 10.1007/s00399-016-0447-1. Review. German.

PMID:
27576696
37.

[Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome - significance, prevention and interdisciplinary management].

Zeymer U, Koscielny J, von Heymann C, Spannagl M, Labenz J, Cremer J, Giannitsis E, Darius H, Goss F.

Dtsch Med Wochenschr. 2016 Jul;141(15):1107-11. doi: 10.1055/s-0042-106944. Epub 2016 Jul 27. Review. German.

PMID:
27464285
38.

Evidence of the bioaccumulation of ciguatoxins in giant clams (Tridacna maxima) exposed to Gambierdiscus spp. cells.

Roué M, Darius HT, Picot S, Ung A, Viallon J, Gaertner-Mazouni N, Sibat M, Amzil Z, Chinain M.

Harmful Algae. 2016 Jul;57(Pt A):78-87. doi: 10.1016/j.hal.2016.05.007. Epub 2016 Jun 23. Erratum in: Harmful Algae. 2017 Mar;63:204.

PMID:
30170724
39.

Fluorescent Receptor Binding Assay for Detecting Ciguatoxins in Fish.

Hardison DR, Holland WC, McCall JR, Bourdelais AJ, Baden DG, Darius HT, Chinain M, Tester PA, Shea D, Quintana HA, Morris JA Jr, Litaker RW.

PLoS One. 2016 Apr 13;11(4):e0153348. doi: 10.1371/journal.pone.0153348. eCollection 2016.

40.

[Anticoagulant activity is rapidly reversed].

Darius H.

MMW Fortschr Med. 2016 Feb 4;158(2):67. German. No abstract available.

PMID:
27017636
41.

Erratum to: Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2015.

Post F, Gori T, Giannitsis E, Darius H, Baldus S, Hamm C, Hambrecht R, Hofmeister HM, Katus H, Perings S, Senges J, Münzel T.

Clin Res Cardiol. 2016 Apr;105(4):376. doi: 10.1007/s00392-016-0960-6. No abstract available.

42.

[Risk-adapted anticoagulation in atrial fibrillation in Germany, Austria and Switzerland - an analysis from the PREFER-in-AF study].

Steffel J, Gwechenberger M, Müller MW, Ammentorp B, Darius H, Kirchhof P.

Dtsch Med Wochenschr. 2015 Nov;140(23):e247-55. doi: 10.1055/s-0041-108996. Epub 2015 Nov 19. German.

PMID:
26583826
43.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators.

JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. Erratum in: JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913.

44.

Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction. Treatment regimens in German chest pain units.

Perne A, Schmidt FP, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T; German Chest Pain Unit Registry.

Herz. 2016 May;41(3):233-40. doi: 10.1007/s00059-015-4355-7. Epub 2015 Sep 28.

PMID:
26411426
45.

Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014.

Post F, Gori T, Giannitsis E, Darius H, Baldus S, Hamm C, Hambrecht R, Hofmeister HM, Katus H, Perings S, Senges J, Münzel T.

Clin Res Cardiol. 2015 Nov;104(11):918-28. doi: 10.1007/s00392-015-0888-2. Epub 2015 Jul 7. Review. Erratum in: Clin Res Cardiol. 2016 Apr;105(4):376.

46.

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.

Brambatti M, Darius H, Oldgren J, Clemens A, Noack HH, Brueckmann M, Yusuf S, Wallentin L, Ezekowitz MD, Connolly SJ, Healey JS.

Int J Cardiol. 2015 Oct 1;196:127-31. doi: 10.1016/j.ijcard.2015.05.141. Epub 2015 May 28.

PMID:
26093161
47.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

48.

Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry.

Härle T, Zeymer U, Hochadel M, Schmidt K, Zahn R, Darius H, Behrens S, Lauer B, Mudra H, Schächinger V, Elsässer A.

Clin Res Cardiol. 2015 Oct;104(10):803-11. doi: 10.1007/s00392-015-0846-z. Epub 2015 Mar 25.

PMID:
25805412
49.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2015 Jun 2;313(21):2185. JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105.

50.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators).

Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.

PMID:
25602175

Supplemental Content

Loading ...
Support Center